Shengjiang Liu

Shengjiang is the Head and principle scientist of Pathogen Safety in Bayer Biological Development. He is also an investor of early stage venture in high-tech and biotech innovation. He was a cofounder and the president of Abmaxis Inc. (acquired by Merck & Co., Inc. in 2006) in antibody engineering and development. He was the group leader and scientist of Genentech (Roche). He discovered rabbit hemorrhagic disease virus (RHDV), rabbit calicivirus, in mid 80s. Dr. Liu received his Ph.D. in biochemistry from Kansas State University and post-doctoral training with Dr. Arthur Kornberg (1993-1996) in Stanford University.